The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Friday broker round-up UPDATE

Fri, 14th Feb 2014 10:26

Assura Group: Liberum Capital shifts target price from 44p to 44.40p and retains a buy recommendation.Barclays: Credit Suisse lowers target price from 270p to 260p and keeps a neutral rating.Bellway: Panmure Gordon raises target price from 1520p to 1639p and maintains a buy recommendation. UBS increases target price from 1875p to 1930p and retains a buy recommendation.Catlin Group: Westhouse Securities cuts target price from 555p to 500p downgrading from neutral to sell.De La Rue: Numis upgrades to add with a target price of 854p.Entertainment One: JP Morgan increases target price from 280p to 356p and maintains an overweight rating.Hikma: Panmure Gordon takes target price from 1350p to 1375p and keeps a buy recommendation.International Consolidated Airlines Group: Deutsche Bank raises target price from 430p to 506p and maintains a buy recommendation.Ladbrokers: UBS upgrades from neutral to buy with a target price of 180p.Lancashire: Deutsche Bank shifts target price from 822p to 826p keeping a hold recommendation. Canaccord Genuity cuts target price from 750p to 720p and reiterates a hold recommendation.Lloyds Banking Group: JP Morgan ups target price from 84p to 95p and upgrades to overweight. Societe Generale shifts target price from 84p to 96p retaining a buy recommendation.Morgan Advanced Materials: JP Morgan takes target price from 330p to 350p and stays with its overweight rating.New World Resources: Jefferies cuts target price from 75p to 50p keeping a hold recommendation.Ophir Energy: JP Morgan lowers target price from 440p to 400p, while retaining an overweight rating.Oxford Instruments: UBS reduces target price from 1850p to 1750p, while its buy recommendation is kept.Petrofac: Berenberg raises target price from 1370p to 1740p upgrading to buy.Phoenix IT: Panmure Gordon shaves target price from 141p to 138p retaining a hold recommendation.PZ Cussons: Panmure Gordon lowers target price from 445p to 430p, while staying with its buy recommendation.Randgold Resources: Numis increases target price from 500p to 5500p and stays with a buy recommendation.Rio Tinto: Citi raises target price from 4000p to 4200p and maintains a buy recommendation. JP Morgan increases target price from 4500p to 4600p keeping an overweight rating. Bank of America reduces target price from 4200p to 3800p and downgrades to neutral.Rolls-Royce: Liberum Capital cuts target price from 1340p to 1300p and leaves its buy recommendation unchanged. Societe Generale reduces target price from 1150p to 1070p, while upgrading to hold.Serco Group: UBS reduces target price from 505p to 400p and stays with a neutral rating.Shire: Societe Generale raises target price from 3615p to 3870p and maintains a buy recommendation. Credit Suisse increases target price from 3200p to 3400p and retains a neutral rating.Tate & Lyle: Panmure Gordon reduces target price from 750p to 680p and reiterates a hold recommendation. Deutsche Bank cuts target price from 1030p to 900p, while its buy recommendation remains unchanged. Citi reduces target price from 900p to 800p, while staying with its buy recommendation. JP Morgan reduces target price from 900p to 825p, while its overweight rating remains unaltered. Credit Suisse reduces target price from 800p to 700p keeping a neutral rating.Telecity Group: Bank of America cuts target price from 650p to 595p and reiterates an underperform rating. UBS reduces target price from 950p to 825p and maintains a buy recommendation.UBM: Credit Suisse reduces target price from 800p to 735p and downgrades to neutral.
More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.